A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples